WWW.DISSERS.RU


...
    !

Pages:     | 1 |   ...   | 28 | 29 ||

231 .., .., .. . // VII . - .-2000. -. 309.

232 .., .., .. . //. . .1994. -N 1. - . 27 -30.

233 .., .., .. . . // . .-1991. -N 1. -.23-26.

234 .., .. 12 .. . // . .-1996.-3.-.-32-35.

235 .., .., .. , , . .: . 1990. -.-238.

236 .., .. - -. // -1998 63, .10. -. 1367-1376.

237 Alpers D., Lock D., Zankaster N. et al. Isolation, characteri sation and assay of lecithin.-// J.Lipid Res., 1985, V.26, p. 1.

" " .., .. 238 Angel A. // Roncari Dak: Med.compicaations of obe- sity.Can.med.Ass.-.1978.-V.119.-p.1401-1415.

239 Assman G. //Lipid metabolism and atherosclerosis.-Stuttgart:

Schattauer Verlag, -1982.-p.34.

240 Assman G., Schmitz H., Menzel H. et al. // Clin.chem, 1983.-V.30, p.641-643.

241 Betterigge D. // G.hum Hypertens.-1989.-V.3.-p.13-25.

242 Blomberg P. // Drugs.-1987.-V.34.-N.9.-p.404-410.

243 Bratton S.L., Davis R.L. Acute Lung injury in isolated traumatic brain injury. // Neurosurgery.-1997.-v.40.-N 4.-P.707-712.

244 Bradbaska S.,Edner G. Solute fibrin and D-dimer as defect of hypercoagualability in patient with isolated brain trauma.//J.of Neurosurgical Anestae-siology.-1994.-.6.-N2.-P.75-82.jo 245 Breslow J. // Human apolipoprotein: molecular biology and genetic variation. // Ann.Rev Biochem.-1985.-V.54.-p.699-727.

246 Brewer H., Gregg R., Horp Y., Fojo S.Clin.Chem.-1988. -V.34.N.8 (B).-p.134-138.

247 Brown M., Goldstein J. A receptor mediated pathway for cholesterol homeostasis // Science.-1986.-V.232.-p.34-47.

248 Brown M., Goldstein G. Familial hypercholesterolemia pathogeneis of receptor disease. // Ann.Russ.Biochem. -1983. -V.52.p.223-261.

249 Brown M., Goldstein G. // Teaching old dogmas tricks. - Nature 1987.-V.330.-p.113-114.

250 Barter P., Hopkins G., Goritschko K. // Atherosclerosis.-1985 - V.58. - N.1-3.-p.97-107.

251 Boskampf E., M Dic Cholesterin-Parabel und der Reigen der Sterine. // Lab. Med.-1986.-V.10.-N.1.-p.25-30.

252 Buchanan M.R., Brister S.J. Semin.Tromb.Hemost.-1993.19, 149157.

253 Ignaro L., Murad F., Nitric Oxid: Biochemistry, Molecular Biologu, and Therapeutic Implications -1995. Adv. Pharmacol.,34.p.1-156.

254 Carlson L., Bottiger L. // Risk factors for ischae- micheart disease in men and women. Results of the 19-th year follow-up of the Stockholm Prospective Study.-acta Med.scand.-1985.-V. 218.p.207-211.

255 Castelli W., Garrison R. et al. // Incidence of co- ronary heart disease and lipoprotein cholesterol levels.-Jama.-1986.-V.256. -p.

2835-2838.

" " .., .. 256 Castelli W. // The triglyceride issue: aview from Framinghaam. J.Am. heart. -1986. -V.112 -p. 432-437.

257 Chang J., Hopkins G., Barter P. //Atherosclerosis.-1985.-V.56. -p.

61-70.

258 Chum J.S., Kang S.S., Jacobson B.S. Mol. Cell.- 1995. - V. 5 - p.114-118.

259 Cullis P.R., Fenske D.B., and Hope M.J. in Biiochemistru jf Lipids Lipoprotein and Membranes (Vance D.E., and Vance J.R., eds) Elsevier, Amsterdam -1996. - P.-1-33.

260 Cucuiani M., Trif L. Rev.roum.Phusiol.,-1992.-29.-p.-33-38.

261 Dacharuprigen J., Toti F., Satta N., Pasguet J., Uzan A., and Freussini J.M. Semin.Thromb.Hemos. -1996.- V.22. -p. 157-164.

262 Deeb S., Distech C., Motulsky A. et al. // Proc.nat.Acad.Sci. 1986. -V.83. -p.419-263 Dielary and pharmacological therapy for the lipid riskfactor. J.amer. med. Ass. -1983. -V.250 -p.1873-1879.

264 Eisenberg S., David D., Oschry Y.et al. // Abnormalities invery low, low and high density lipoproteins in hypertriglyceridemia. - Lipid Res. - 1987. -V.8.-p.470-474.

265 Eisenberg S. // High density lipoprotein metaboli- sm- Lipid Res.1984.- V.25.-p.1017-1058.

266 Fielding P., Fielding C. // A cholesteryl ester trasfer complex in human plasma. -Proc.nat.Acad. Sci.1980. -V.77. -p. 3327-3330.

267 Fredrickson D. // Medical concepts cardiovasc.dis.1971.-V.41. p.31-36.

268 Freedom D., Jacobson S., Bartoriak G. et al. // Circulation. 1990. - V.81. -p. 1498-1506.

269 Freedom D., Jacobson S., Bartoriak G. et al. // Circulation. 1990. - V.81. -p.1498-1506.

270 Frische K., Cassitu N. Prostag.Leukot.Essen.Fattu Acids.-1996. -p.

315-323.

271 Frick M., Elo O., Haapa K., et al. // Helsinki he- art study: primary prevention trial with gemfibrozil in mid- dle-agedmen with dyslipidaemia.- New Engle J.Med.-1987.-V. 317.-p.1237-1245.

272 Frucharf J. // LDL at atherogenese: nouveaux conce- pt.sem. Hin.

-1989. - V.65. -N 3.-p.91-95.

273 Fratianne R.B. Branlt C.P. // Burn Care Rehabil.1997.-Vol.,3. P.262-267 discur.P. 260-261.

274 Galle J., Bassenge E., Busse R. // Circulation Res. -1990. -V. 66. p. 1287-1293.

" " .., .. 275 Goldstein J., Brown M. // Regulation of low densitylipoprotein receptors: implications for pathogenesis and the- rapy of hyper cholesterolemia and atherosclerosis.-.Lipid Res. -1984. -V. 25. p. 1450.

276 Hail E.D., Braughler J.M., McCall J.M. Antioxidant effects in drain and spinal cord injury. (Review). // Journal of Neurotrauma.

-1992. - Vol.9. -Suppl.1. - P. 47-63.

277 Hall E.D. Lipid antioxidants in acute central nervous sistem injury.

(Review). // Annals of Emergency Medicine.-1993.-Vol.22.-N.6.p.1022-1027.

278 Hall E.D.The role of oxygen radicalsi traumatc injury.(Review) clinica implications.// Journal of Emergency Medicine.1993.Vol.11. -Supp.11-P.-31-36.

279 Hanchok J., ahd Neill S. et al.Sterjids. // Biochemist.-1994. -V.59.

N.8.-p.46-54.

280 Hoeg J., Demosky S., Edge et al. Characterization of human hepatic receptor for high density lipoproteins. Arteriosclerosis. 1985. -V. 5.-p.228- 237.

281 Hulley S., Rosenman R., Baroal R.,et al. // Epide-miology as a guide to clinical deciscion. The association between triglyceride and coronary heart desease. - N.Engl.J.Med., - 1980, -V. 302. -p.

1383-1389.

282 Janani M., Zacko A. // A study of the interaction of lecithin:Cholesterol acyltransferase with subtraction of high density lipoproteins. -J.Lipid Res. - 1981.

283 Kissebah A. //Stress hormones and lipid metabolism.-Proc.Roy.

Soc.Med.. -1974. -V. 67. -N 7.-p. 665.

284 Kostner S., Karach J. // Diabetologia. -1988. -V.31. -p. 717 -722.

285 Kusa O., Luknarowa O., Riecansky J. // Lipoproteinovy cholesterol i pacientov s ischeprickou chorobou.- Zek.obzor. - 1986. -V.

35. -N 3.-p. 97-102.

286 Kurashvili L.et al. State of metabolistm and liver hemodynamics of the patients syffering from the surgical abdominal patholody dyring the intensive therapy treatment // 9 European Congress on Intensive Care Medicine.-1996. Glasgow.

287 Lefedvre P., Coben J. Blood Coagul.Fidrinolus. -1992.-V. -p. 237241.

288 Lusis A. // Genetic factor affecting blood:the candidate geneapproach. -J.Lipid res., -1988. -V. 29.-p. 397-429.

289 Marcel J., Vezina C., Teng B., Sniderman A. // Atherosclerosis. 1980. - V.35. N 1.

" " .., .. 290 Mc Garry., Foster D. // Regulation of hepatic fatty acidoxida tion and ketons body production.-Ann.rev.biochem. -1980.- V. 9.-p.

395.

291 Miller N., Miller G. // Clinical and metabolism aspect of high density lipoproteins. New Jork-Amsterdam-Oxford: Elsevier.-1984.p. 142.

292 Miller N., Rajput-Willimas I., Ninja M. et al. // Atherosclerosis. - 1988. V. 69. -p.123-126.

293 Morrill A.H., Swoolou C.C. in Biochemistry of Lipids, Lipoprotein and Membranes (Vance, D.e.,and acne, I.R.,EDS), Elsevier, Amsterdam, -1996.-p.309-339.

294 Murad f. -1994. Neurotransmission,10. -p. 1-4.

295 Neii G., Crouse J., Furberg G. // Stroke. -1988. - V. 19. -p. 423430.

296 Negri S., Romo P., Fogliatto R., et al. // Atherosclerosis. - V.101. - p.37- 41.

297 Nikkila E. // Familial lipoprotein lipase deific- fence and related disorders of chylomicron metabolism. - N - York. -1983.-p. 622642.

298 Peden V. // Determination of individual serum. - Ketene Bodies with normal values in infants and children. - J.clin. med. -1964. V.63. - N 2. - p.332.

299 Pillet P., Hallidau D., Bateman P. // Site difference in the fatty acid composition of subcutaneous adipose tissue of obese women. // Brit.J.Nutr. -1979. -V.42. -N 1. - P.57-61.

300 Ross R. The pathogenesis of atherosclerosis-an update. N.Engle. // J.Med. -1986. -V.314. -p.489-500.

301 Ross R. // Platelet - derived growth factors. -Ann. Rev. Med.1987. -V. 382. -p.71-79.

302 Salbach P.B., Specht E., Janssen-Timmen U.,et.al. -A.J.R. -1992.

// Proc. Natl. Acad. Soy. USA. -89. -p.2439-2443.

303 Serhar C.N., Haeggstron J.Z., Leslie C.C., Faseb J. -1996.-V. -10.

-p.1147-1158.

304 Severina J.S., Belushkina N.N. Biochem.Jnternat.1992. -V.28. P.621-631.

305 Severina J.S. Adv.Fnzume Redul. 1992. V.32. P.35-56.

306 Simon B.C., Cunningham L.D., Cohen R.A. // J.Clin Invest 1990.- V.-86. -p. 75-79.

307 Surua J.J., Gorter G., Mommer-steed M.-1993. Biochem.Biophus.Acta. 11. 65 pp. 19-26.

" " .., .. 308 Schenberg D. // The participation of oxygen free radicals in septic shock.-Septic chock: Eur.view. - Berlin. - 1987. - p. 108 -115.

309 Schmidt V., Habiert H. " " -1980. - V.73. - p. 227 - Clinical and metabolic aspects of highdensity lipoproteins.

310 Shohet S. " ". -M.-1980. -p.325343.

311 Sies H. Oxidative stress. From basis research to dinical application. // Amer. J. Med. -1991.-v.91.-Suppl.Sc.-P.S.-S.38.

312 Sies H. Oxidative stress: introductory remare. // Oxidative stress.London.-Acad. Press. -1985. -P.1-7.

313 Simpson H., Mann G. // Hypertriglyceridaemia and hypercoagula bility. Fancet. -1983. - p.786-790.

314 Soni N. Cellular metabolism. /Scientific foundation of anaesthesia.

//Eds. C. Seurr et al. Oxford. -1990.-P.380-391.

315 Slutsky G., Pascard J. // Lipoproteins, apoliproteins and cholesterol in cardiovas - cular disease. -Europ.clin.lab. -1988. - sept.oct. -p. 28-36.

316 Spiegel S., Foster D., and Kolesnik K.(1996) Curr. Opinion in Cell Biol., 8, 159-161.

317 Smith W., Am.J.Phusiol. -1992. -263. -F 181-F 191.

318 Smith S. // Clinical chem. -1985. -V.31.- N 5 - p. 746-750.

319 Tollefson I., Albers J. // Isolation, characteri- zation and assay of plasma lipid transfer proteins.-In.Met- hods in Enzymoto-logy. - London. Academies Press. -V. 129. -1986. -p. 797-816.

320 Utermann G. // Apolipoprotein polimorphism and mulifactorial hyperlipida-emia.- J.inher. Metab.dis.-1988.-suppl.1.-p. 74-86.

321 Van Berkel T., Nagelker J., Harker L. // Liver se- nuscidal cells and lipoproteins metabolisme.-1982.-p.305-318.

322 Watanabe A., Voshimura A., Wakasugi T. et al. // Serum lipid, lipoprotein lipids and coronary heart disease in patients with xanthelasma palpeb-rarum. Atherosclerosis. -1981. -V. 38. -p.

238-290.

323 Waeldius G. // Atherosclerosis. - Eds.N.Fidge., P.Nes - tel. Amsterdam. -1986. -p. 205-222. 274.

324 Zammit V. // Intra- hepatic regulation of ketogenasis. - Trends in Biochem. Scie- nces. - 1981. -p. 46.

" " .., .. 325 Zammit V. //Intrahepatic regulation of ketogenasis. -Trends in Biochem. Sciences.-1981.-p.69.

326 Zhu Y., Schieber E.B., Mogiff J.C., Balazu M. Hupeten sion. - 1995. -V. 25. -p. 854-859.

.

....... ...................................... , Յ...

- ........................................ - ⅅ....................... - 텅............................. - .................... - ......................... - ................................ - .................................. - - .......................... - - ...... - ................. - . ..

Pages:     | 1 |   ...   | 28 | 29 ||



2011 www.dissers.ru -

, .
, , , , 1-2 .